Cerevast Therapeutics, Inc. Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
Cerevast Therapeutics, Inc is a medical technology company focused on the development of a new therapy for the treatment of acute ischemic stroke. Cerevast’s technology harnesses the acoustic energy from ultrasound to disrupt or “lyse” blood clots in the vasculature. This technology is called SonoLysis therapy. Clinical studies have demonstrated that the combination of transcranial ultrasound with conventional drug therapy breaks-up blood clots more effectively and results in better long-term functional outcomes compared to current drug therapy alone – a major advancement in the treatment of stroke.